4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001193125-26-276882
Chief Executive Officer acquired 375,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Barrow Robert · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-22 | Grant or award : show line 1 in the form | +375,000 | 1,127,454 | D |
Loading xslF345X06/ownership.xml…